Last reviewed · How we verify
NCT07082933
Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes
trial testing Standard medical treatment in Pulmonary Arterial Hypertension (PAH) in 5,000 participants. Not yet recruiting.
1 August 2027
Quick facts
| Lead sponsor | Xijing Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 August 2025 |
| Primary completion | 1 August 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- Standard medical treatment — full drug profile →
Conditions studied
- Pulmonary Arterial Hypertension (PAH) — all drugs for Pulmonary Arterial Hypertension (PAH) →
Sponsor
Xijing Hospital
Who can join
Adults 18 to 80, any sex, with Pulmonary Arterial Hypertension (PAH). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07082933
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard medical treatment
Trials testing the same drug.
- NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
- NCT07397117 — Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care · NA · recruiting
- NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
- NCT07445035 — Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation · NA · not yet recruiting
- NCT07471256 — Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorr · Phase 3 · not yet recruiting
Other recruiting trials for Pulmonary Arterial Hypertension (PAH)
Currently open trials in the same condition.
- NCT07245680 — COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities · Phase 3 · recruiting
- NCT06872112 — A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension · Phase 1 · recruiting
- NCT07013149 — The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension · recruiting
- NCT07457762 — AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension? · NA · recruiting
- NCT06941441 — PAH Exercise Study · Phase 3 · recruiting
Other Xijing Hospital trials
Trials by the same sponsor.
- NCT07532096 — Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast · NA · not yet recruiting
- NCT07519018 — TIS for Drug Resistant TLE · NA · not yet recruiting
- NCT07518992 — Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction · not yet recruiting
- NCT07466303 — Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer · Phase 2 · not yet recruiting
- NCT07474142 — A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve P · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07082933 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xijing Hospital
- Last refreshed: 24 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07082933.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing